"10.1371_journal.pone.0003363","plos one","2008-10-09T00:00:00Z","Søren Søgaard Lund; Lise Tarnow; Anne Sofie Astrup; Peter Hovind; Peter Karl Jacobsen; Amra Ciric Alibegovic; Ida Parving; Lotte Pietraszek; Merete Frandsen; Peter Rossing; Hans-Henrik Parving; Allan Arthur Vaag","Steno Diabetes Center, Gentofte, Denmark; Rigshospitalet, Department of Medical Endocrinology, University of Copenhagen, Copenhagen, Denmark; Faculty of Health Sciences, University of Aarhus, Aarhus, Denmark; Department of Endocrinology, University of Lund, Malmö, Sweden","Conceived and designed the experiments: SSL LT PKJ HHP AV. Performed the experiments: SSL LT ASA PH ACA IP LP MF. Analyzed the data: SSL PR AV. Wrote the paper: SSL LT ASA PH PKJ ACA IP LP MF PR HHP AV.","Søren S. Lund, Lise Tarnow, Anne Sofie Astrup, Peter Hovind, Peter K. Jacobsen, Amra Ciric Alibegovic, Ida Parving, Lotte Pietraszek, Merete Frandsen, Peter Rossing, Hans-Henrik Parving and Allan Vaag have reported equity in Novo Nordisk A/S. Lise Tarnow, Hans-Henrik Parving and Allan A. Vaag has received funds from Novo Nordisk A/S for research. Søren S. Lund and Allan A. Vaag have received fees from Novo Nordisk A/S for speaking and Allan A.Vaag has received fees from Novo Nordisk A/S for organising education. All authors are present or former employees at Steno Diabetes Center, Gentofte, Denmark. Steno Diabetes Center is an independent academic institution owned by Novo Nordisk A/S and The Novo Nordisk Foundation.","2008","10","Søren Søgaard Lund","SSL",12,TRUE,5,8,3,12,TRUE,TRUE,FALSE,0,NA,FALSE
